Pharmacopeia
MINOXIDIL
Core pharmacology
- Class Group
Direct Vasodilator
- Legacy Cicm Level
-
- Introduction
direct vasodilator whose mechanism of action is poorly understood.
- Indications Uses
It is used primarily in severe refractory hypertension in combination with other antihypertensives
Topical to treat baldness- Presentation
10mg tablets
Topical- Mechanism of action
Poorly understood. May be potassium channel activator)
↑hair production
- Onset Peak Duration
PO. doses 10-40mg PO daily
- Physiological effects
Arteriole vasodilation with preserved venous tone, and minimal effect on epicardial vasculature. Reflex ↑ in HR, CO and activation of the RAAS → peripheral oedema.
- Adverse Effects Toxicity
activation of the RAAS and the increase in HR and CO make this drug less
efficacious. Because of this reason it is almost always given in combination with a
thiazide or betablocker. It is contraindicated in phaechromocytoma and may
precipitate pericardial eff¬usion and worsen angina.- Absorption
PO. BA up to 90%
- Protein binding
None
- Metabolism
Hepatic primarily via glucuronidation
- Excretion
Urine (12% as unchanged drug)
- Half-life
4 hours
- Route And Dose
PO. doses 10-40mg PO daily